Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio
Jorge
J
Germà
José R
JR
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D009367:Neoplasm Staging; D016609:Neoplasms, Second Primary / Q000209:etiology*; D009919:Orchiectomy; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000556:secondary; D018570:Risk Assessment; D016879:Salvage Therapy; D018239:Seminoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome
D016190:Carboplatin